| Literature DB >> 33261633 |
Jean Tittley1,2, Luc J Hébert1,2,3, Jean-Sébastien Roy4,5.
Abstract
STUDYEntities:
Keywords: Cryotherapy; Lateral ankle sprain; Neurocryostimulation; Rehabilitation
Mesh:
Substances:
Year: 2020 PMID: 33261633 PMCID: PMC7708120 DOI: 10.1186/s13047-020-00436-6
Source DB: PubMed Journal: J Foot Ankle Res ISSN: 1757-1146 Impact factor: 2.303
Fig. 1Study Design. NCS: neurocryostimulation
Fig. 2Flowchart of Participants. MRI: magnetic resonance imaging; NCS: neurocryostimulation; PT: physiotherapist
Participants’ baseline characteristics
| NCS group ( | Ice group ( | ||
|---|---|---|---|
| Age, years, X̅ ± SD | 26.9 ± 9.1 | 28.3 ± 9.8 | |
| Gender, # (% of allocation group) | Female | 10 (50%) | 10 (48%) |
| Male | 10 (50%) | 11 (52%) | |
| Weight, kg, X̅ ± SD | 73.8 ± 12.9 | 72.1 ± 14.4 | |
| Height, cm, X̅ ± SD | 172.4 ± 9.3 | 171.9 ± 9.4 | |
| Body mass index, kg/m2, X̅ ± SD | 24.8 ± 3.8 | 24.5 ± 5.6 | |
| Number of previous ankle sprains, X̅ ± SD | Same ankle | 0.9 ± 1.4 | 1.0 ± 1.4 |
| Any ankle | 1.9 ± 2.8 | 1.5 ± 2.1 | |
| Physical activity, mean hours/week last 12 months, X̅ ± SD | 10.6 ± 8.2 | 7.1 ± 4.5 | |
| Days from injury to initial assessment, X̅ ± SD | 2.4 ± 0.9 | 2.0 ± 1.1 | |
| Days from injury to 1st treatment, X̅ ± SD | 3.0 ± 1.1 | 2.5 ± 1.1 | |
NCS neurocryostimulation, SD standard deviation, X̅ mean. There was no statistical difference between the two groups for all variables (P ≥ 0.05; independent t-tests or Chi-squared tests).
Results (p-values) of ANOVA-type analysis (nparLD) for the intention-to-treat analysis
| Group effect | Time effect | Group X Time interaction | |
|---|---|---|---|
| Functional capacity (LEFS) | 0.404 | < 0.0001 | 0.727 |
| Pain at rest | 0.390 | < 0.0001 | 0.057 |
| Pain during usual activities | 0.995 | < 0.0001 | 0.648 |
| Oedema (Figure-of-8) | 0.563 | < 0.0001 | 0.242 |
| Dorsiflexion ROM (WBLT) | 0.408 | < 0.0001 | 0.766 |
LEFS Lower Extremity Functional Scale, nparLD non-parametric longitudinal data, ROM range of motion, WBLT Weight Bearing Lunge Test.
Group marginal estimated means for all outcomes. Data expressed as mean ± standard error of the mean (SEM)
| NCS | Ice | |
|---|---|---|
| Baseline | 29.6 ± 1.7 | 34.7 ± 2.5 |
| 1 week | 51.5 ± 2.9 | 52.2 ± 2.6 |
| 2 weeks | 62.4 ± 2.3 | 64.7 ± 2.0 |
| 4 weeks | 72.2 ± 1.9 | 73.0 ± 1.1 |
| 6 weeks | 74.7 ± 1.3 | 76.3 ± 0.8 |
| Baseline | 1.9 ± 0.4 | 2.2 ± 0.4 |
| 1 week | 1.5 ± 0.4 | 0.9 ± 0.2 |
| 2 weeks | 0.8 ± 0.3 | 0.3 ± 0.1 |
| 4 weeks | 0.2 ± 0.2 | 0.1 ± 0.1 |
| 6 weeks | 0.1 ± 0.1 | 0.1 ± 0.0 |
| Baseline | 4.5 ± 0.5 | 4.6 ± 0.4 |
| 1 week | 2.4 ± 0.4 | 2.3 ± 0.4 |
| 2 weeks | 1.7 ± 0.4 | 1.2 ± 0.2 |
| 4 weeks | 0.7 ± 0.3 | 0.5 ± 0.2 |
| 6 weeks | 0.4 ± 0.2 | 0.2 ± 0.1 |
| Baseline | 53.7 ± 0.7 | 52.7 ± 0.8 |
| 1 week | 53.0 ± 0.7 | 52.0 ± 0.8 |
| 2 weeks | 52.6 ± 0.7 | 52.1 ± 0.8 |
| 4 weeks | 52.4 ± 0.6 | 51.7 ± 0.7 |
| 6 weeks | 52.5 ± 0.7 | 51.9 ± 0.8 |
| Baseline | 5.5 ± 0.8 | 5.9 ± 1.0 |
| 1 week | 7.9 ± 0.9 | 9.4 ± 0.5 |
| 2 weeks | 9.6 ± 0.7 | 10.6 ± 0.5 |
| 4 weeks | 10.7 ± 0.5 | 11.7 ± 0.5 |
| 6 weeks | 11.2 ± 0.5 | 11.7 ± 0.6 |
LEFS Lower Extremity Functional Scale, NCS neurocryostimulation, ROM range of motion, VAS visual analog scale, WBLT Weight-Bearing Lunge Test.
Outcomes changes over time compared to baseline values throughout treatment (marginal estimated mean improvements), by group
| Mean score change (95% CI) | Time main | ||
|---|---|---|---|
| NCS | Ice | ||
| 1 week | 22.0 (13.6 to 30.3) | 17.6 (10.2 to 25.0) | 0.340 |
| 2 weeks | 32.8 (26.0 to 39.6) | 30.1 (22.4 to 37.7) | 0.514 |
| 4 weeks | 42.7 (37.2 to 48.1) | 38.3 (31.1 to 45.6) | 0.716 |
| 6 weeks | 45.2 (40.3 to 50.0) | 41.6 (33.5 to 49.7) | 0.800 |
| 1 week | − 0.4 (+ 0.8 to − 1.5) | −1.3 (− 0.6 to − 2.1) | 0.375 |
| 2 weeks | −1.1 (+ 0.2 to − 2.3) | −1.9 (− 0.8 to −3.0) | 0.534 |
| 4 weeks | − 1.6 (− 0.3 to − 2.9) | − 2.1 (− 0.8 to − 3.4) | 0.668 |
| 6 weeks | − 1.8 (− 0.6 to − 2.9) | − 2.2 (− 0.9 to − 3.4) | 0.705 |
| 1 week | − 2.1 (− 0.6 to − 3.6) | − 2.3 (− 1.3 to − 3.3) | 0.382 |
| 2 weeks | −2.8 (− 1.5 to − 4.2) | −3.4 (− 2.4 to − 4.4) | 0.490 |
| 4 weeks | −3.8 (− 2.4 to − 5.2) | −4.1 (− 2.9 to − 5.3) | 0.682 |
| 6 weeks | −4.1 (− 2.7 to − 5.6) | −4.4 (− 3.2 to − 5.6) | 0.774 |
| 1 week | −0.69 (− 0.05 to − 1.34) | −0.64 (+ 0.11 to − 1.38) | 0.496 |
| 2 weeks | − 1.06 (− 0.29 to − 1.83) | −0.56 (+ 0.28 to − 1.40) | 0.508 |
| 4 weeks | − 1.24 (− 0.29 to − 2.18) | −0.93 (− 0.19 to − 1.67) | 0.532 |
| 6 weeks | −1.15 (− 0.20 to − 2.09) | −0.76 (− 0.05 to − 1.47) | 0.519 |
| 1 week | 2.4 (− 0.1 to 4.9) | 3.6 (1.1 to 6.0) | 0.414 |
| 2 weeks | 4.1 (1.9 to 6.3) | 4.8 (2.2 to 7.4) | 0.550 |
| 4 weeks | 5.2 (3.0 to 7.4) | 5.9 (3.2 to 8.6) | 0.643 |
| 6 weeks | 5.7 (3.4 to 8.0) | 5.9 (3.1 to 8.7) | 0.668 |
aRelative treatment effect (nparLD analysis), for appreciation of the time main effect. Corresponds to an effect size of the time. Values range [0, 1], relative to the null hypothesis (H0) expected value (0,5)
LEFS Lower Extremity Functional Scale, NCS neurocryostimulation, ROM range of motion, RTE relative treatment effect, VAS visual analog scale, WBLT Weight-Bearing Lunge Test.
Fig. 3LEFS Scores. Lower Extremity Functional Scale (LEFS) mean scores (larger markers) for NCS group (n = 20) and ice group (n = 21), and individual scores (smaller markers). Higher scores indicate better function. Error bars show standard deviation (SD) of the means. NCS: neurocryostimulation
Fig. 4Pain at Rest Scores. Pain intensity at rest during the last 48 h. Data show mean scores (larger markers) for NCS group (n = 20) and ice group (n = 21), and individual scores (smaller markers). Error bars show standard deviation (SD) of the means. NCS: neurocryostimulation; VAS: visual analog scale
Fig. 5Pain during Usual Activities Scores. Pain intensity during usual activities for the last 48 h. Data show mean scores (larger markers) for NCS group (n = 20) and ice group (n = 21), and individual scores (smaller markers). Error bars show standard deviation (SD) of the means. NCS: neurocryostimulation; VAS: visual analog scale